Some South American Rodent-Borne Viruses May Spread as Climate Warms

Why It Matters

The projected spread of rodent‑borne arenaviruses could generate high‑mortality hemorrhagic fever outbreaks in previously unaffected areas, straining health systems lacking specific therapies. Early mapping enables targeted monitoring and prevention, potentially averting costly epidemics.

Key Takeaways

• Climate-driven habitat shifts could expand arenavirus risk to new South American regions
• Models predict Guanarito, Junin, Machupo viruses reach Brazil, Paraguay, Peru by 2060
• No approved treatments exist; only a Junin vaccine is licensed in Argentina
• Farmworkers face heightened exposure as rodents move into agricultural zones
• Early surveillance using risk maps can guide preventive measures before outbreaks occur

Pulse Analysis

Climate change is reshaping the ecological landscape of South America, forcing wildlife to migrate in search of suitable temperature and moisture regimes. Among the most concerning movers are rodents that serve as reservoirs for arenaviruses—a family that includes the lethal Lassa fever virus in Africa and several hemorrhagic fever agents native to the continent. As temperatures rise and precipitation patterns shift, these mammals can colonize higher latitudes and altitudes, bringing pathogens like Guanarito, Junin and Machupo into contact with human populations that have never encountered them before.

The research team at UC Davis combined species‑distribution models with the latest climate projections and demographic data to generate risk maps for six rodent hosts. Their simulations indicate that by 2060, the endemic zones of Guanarito virus could extend from central Venezuela into Colombia, Guyana, Suriname and Brazil, while Junin and Machupo viruses may appear in new Argentine, Paraguayan, Bolivian and Peruvian locales. The analysis also flags agricultural and urban expansion as amplifiers of exposure, especially for farmworkers who live and work in close proximity to the shifting rodent populations. No approved antivirals exist, and only an Argentine‑licensed Junin vaccine offers limited protection.

These findings give public‑health agencies a data‑driven tool to prioritize surveillance in emerging hotspots before human cases surface. Early detection, combined with community education and targeted rodent control, could blunt the impact of a potential hemorrhagic fever outbreak that would otherwise strain under‑resourced health systems. Moreover, the study underscores the urgency of expanding vaccine pipelines for arenaviruses and integrating climate‑adaptation strategies into infectious‑disease preparedness plans worldwide. As the planet warms, proactive mapping of zoonotic risk will become an essential component of global health security.